Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: Results of the prospective INES 99.1

Journal of Clinical Oncology

Volumn 29, Issue 4, 2011, Pages 449-455

  Rubie, Hervé ^a   De Bernardi, Bruno ^a   Gerrard, Mary ^a   Canete, Adela ^a   Ladenstein, Ruth ^a   Couturier, Jérôme ^a   Ambros, Peter ^a   Munzer, Caroline ^a   Pearson, Andrew D J ^a   Garaventa, Alberto ^a   Brock, Penelope ^a   Castel, Victoria ^a   Valteau Couanet, Dominique ^a   Holmes, Keith ^a   Di Cataldo, Andrea ^a   Brichard, Bénédicte ^a   Mosseri, Véronique ^a   Marquez, Catalina ^a   Plantaz, Dominique ^a   Boni, Luca ^a   Michon, Jean ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; DRUG EFFICACY; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE PLANNING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; GENE AMPLIFICATION; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952094688     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.5196     Document Type: Article

References (22)

1. Bernstein ML, Leclerc JM, Bunin G, et al: A population-based study of Neuroblastoma incidence, survival and mortality in North America. J Clin Oncol 10:323-329, 1992
2. Hartmann O, Scopinaro M, Tournade MF, et al: Neuroblastomes traité s à l' Institut Gustave Roussy de 1975 à 1979: Cent soixante treize cas [French]. Arch Fr Pédiatr 40:15-21, 1983
3. Evans AE, Albo V, D' angio GJ, et al: Factors influencing survival of children with non metastatic neuroblastoma. Cancer 38: 661-666, 1976
4. Le Tourneau JN, Bernard JL, Hendren WH, et al: Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20:244-249, 1985 (Pubitemid 15006430)
5. De Bernardi B, Conte M, Mancini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
6. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993 (Pubitemid 23277331)
7. West DC, Shamberger RC, Macklis RM, et al: Stage III neuroblastoma over 1 year at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11:84-90, 1993 (Pubitemid 23059979)
8. Rubie H, Michon J, Plantaz D, et al: Unresectable localized neuroblasroma: Improved survival after primary chemotherapy including carboplatin-etoposide. Br J Cancer 77:2310-2317, 1998 (Pubitemid 28263959)
9. Rubie H, Plantaz D, Coze C, et al: Localised and unresectable neuroblastoma in infants: Excellent outcome with primary chemotherapy. Med Pediatr Oncol 36:247-250, 2001
10. Matthay KK, Perez C, Seeger RC, et al: Successful treatment of Stage III Neuroblastoma based on prospective biologic staging: A Children's Cancer Group Study. J Clin Oncol 16: 1256-1264, 1998 (Pubitemid 28175737)
11. Bergeron C, Dubourg L, Chastagner, et al: Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: Results of the SFOP NBL90 study. Pediatr Blood Cancer 45: 32-36, 2005 (Pubitemid 40791743)
12. Rubie H, Coze C, Plantaz, et al: Localized and unresectable neuroblastoma in infants: Excellent outcome with low-dose primary chemotherapy. Br J Cancer 89: 1605-1609, 2003 (Pubitemid 37464127)
13. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 11: 1466-1477,1993 (Pubitemid 23228250)
14. Ambros I, Benard J, Boavida M, et al: Quality assessment of genetic markers used for therapy stratification. J Clin Oncol 21:2077-2084, 2003 (Pubitemid 46606355)
15. Cechetto G, Mosseri V, De Bernardi B, et al: Surgical risk factors in primary surgery for localized neuroblastoma: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol 23:8483-8489, 2005
16. Monclair T, Brodeur GM, Ambros PF, et al: The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report. J Clin Oncol 27:198-303, 2009
17. Rubie H, Hartmann O, Michon J, et al: Localized neuroblastoma: N-Myc gene amplification is a major prognostic factor: Results of the French NBL 90 study. J Clin Oncol 15:1171-1182, 1997
18. Canete A, Gerrard M, Rubie H, et al: Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: The International Society of Pediatric Oncology European Neuroblastoma Experience. J Clin Oncol 27: 1014-1019, 2009
19. Plantaz D, Rubie H, Michon, et al: The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease: A prospective study of 42 cases: Results of the NBL 90 study of the French Society of Pediatric Oncology. Cancer 78: 311-319, 1996 (Pubitemid 26234576)
20. Kushner BH, Cheung NKV, Laquaglia MP, et al: Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996 (Pubitemid 26050997)
21. Hero B, Simon T, Spitz R, et al: Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB-95 and NB-97. J Clin Oncol 26:1504-1510, 2008
22. Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, et al: Accumulation of segmental alterations determines progression in neuroblastoma J Clin Oncol 28:3122-3130, 2010